Alternative Antibiotics to Penicillin for Adult Strep Throat

Treatment Algorithm Based on Type of Penicillin Allergy

For adults with non-immediate penicillin allergy, the American College of Physicians recommends first-generation cephalosporins, such as cephalexin 500 mg twice daily for 10 days or cefadroxil 1 gram once daily for 10 days, with strong, high-quality evidence 1, 2
The Infectious Diseases Society of America suggests that up to 10% of patients with immediate hypersensitivity to penicillin may have cross-reactivity with first-generation cephalosporins, so these should be avoided in patients with a history of anaphylaxis, angioedema, or urticaria to penicillin 1, 3

The Centers for Disease Control and Prevention recommend that all antibiotics except azithromycin require a full 10-day course to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever 1, 3

The evidence hierarchy for penicillin alternatives is led by first-generation cephalosporins for non-immediate allergy, with strong, high-quality evidence from multiple guidelines, including the American Heart Association 1, 2
Clindamycin has strong, moderate-quality evidence, particularly effective in treatment failures and carriers, as recommended by the American Academy of Pediatrics 1, 2

The American College of Physicians advises against prescribing shorter courses than recommended, except for azithromycin's 5-day regimen, to prevent treatment failure and acute rheumatic fever 1, 3
The Infectious Diseases Society of America warns against assuming all penicillin-allergic patients cannot receive cephalosporins, as only those with immediate/anaphylactic reactions should avoid cephalosporins due to the 10% cross-reactivity risk 1, 3

The American Academy of Family Physicians suggests that chronic carriers generally do not require antimicrobial therapy, but if treatment is indicated, clindamycin is particularly effective due to its ability to eradicate the organism 1, 2
The Centers for Disease Control and Prevention recommend against routine post-treatment cultures for asymptomatic patients who have completed therapy, except in special circumstances such as patients with a history of rheumatic fever 2